| A pooled analysis of bone marrow micrometastasis in breast cancer S Braun, FD Vogl, B Naume, W Janni, MP Osborne, RC Coombes, ... New England journal of medicine 353 (8), 793-802, 2005 | 1685 | 2005 |
| Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study T Kuehn, I Bauerfeind, T Fehm, B Fleige, M Hausschild, G Helms, ... The lancet oncology 14 (7), 609-618, 2013 | 1626 | 2013 |
| Systemic spread is an early step in breast cancer Y Hüsemann, JB Geigl, F Schubert, P Musiani, M Meyer, E Burghart, ... Cancer cell 13 (1), 58-68, 2008 | 1510 | 2008 |
| Circulating tumor cells in patients with breast cancer dormancy S Meng, D Tripathy, EP Frenkel, S Shete, EZ Naftalis, JF Huth, PD Beitsch, ... Clinical cancer research 10 (24), 8152-8162, 2004 | 1197 | 2004 |
| Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ... The lancet oncology 15 (4), 406-414, 2014 | 974 | 2014 |
| Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients B Aktas, M Tewes, T Fehm, S Hauch, R Kimmig, S Kasimir-Bauer Breast cancer research 11, 1-9, 2009 | 903 | 2009 |
| Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of … C Rödel, T Liersch, H Becker, R Fietkau, W Hohenberger, T Hothorn, ... The lancet oncology 13 (7), 679-687, 2012 | 867 | 2012 |
| Early dissemination seeds metastasis in breast cancer H Hosseini, MMS Obradović, M Hoffmann, KL Harper, MS Sosa, ... Nature 540 (7634), 552-558, 2016 | 743 | 2016 |
| Circulating tumor cells predict survival in early average-to-high risk breast cancer patients B Rack, C Schindlbeck, J Jückstock, U Andergassen, P Hepp, T Zwingers, ... Journal of the National Cancer Institute 106 (5), dju066, 2014 | 707 | 2014 |
| HER-2 gene amplification can be acquired as breast cancer progresses S Meng, D Tripathy, S Shete, R Ashfaq, B Haley, S Perkins, P Beitsch, ... Proceedings of the National Academy of Sciences 101 (25), 9393-9398, 2004 | 679 | 2004 |
| Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer G von Minckwitz, H Eidtmann, M Rezai, PA Fasching, H Tesch, ... New England Journal of Medicine 366 (4), 299-309, 2012 | 623 | 2012 |
| Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial S Riethdorf, V Müller, L Zhang, T Rau, S Loibl, M Komor, M Roller, ... Clinical cancer research 16 (9), 2634-2645, 2010 | 603 | 2010 |
| Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant T Fehm, A Sagalowsky, E Clifford, P Beitsch, H Saboorian, D Euhus, ... Clinical cancer research 8 (7), 2073-2084, 2002 | 424 | 2002 |
| HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial T Fehm, V Müller, B Aktas, W Janni, A Schneeweiss, E Stickeler, ... Breast cancer research and treatment 124, 403-412, 2010 | 416 | 2010 |
| Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study F Amant, G von Minckwitz, SN Han, M Bontenbal, AE Ring, J Giermek, ... Journal of clinical oncology 31 (20), 2532-2539, 2013 | 402 | 2013 |
| Pooled analysis of the prognostic relevance of circulating tumor cells in primary breast cancer WJ Janni, B Rack, LWMM Terstappen, JY Pierga, FA Taran, T Fehm, ... Clinical Cancer Research 22 (10), 2583-2593, 2016 | 393 | 2016 |
| Treatment of breast cancer during pregnancy: an observational study S Loibl, SN Han, G von Minckwitz, M Bontenbal, A Ring, J Giermek, ... The lancet oncology 13 (9), 887-896, 2012 | 389 | 2012 |
| Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and … CS Schuetz, M Bonin, SE Clare, K Nieselt, K Sotlar, M Walter, T Fehm, ... Cancer research 66 (10), 5278-5286, 2006 | 385 | 2006 |
| Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells S Kasimir-Bauer, O Hoffmann, D Wallwiener, R Kimmig, T Fehm Breast Cancer Research 14, 1-9, 2012 | 373 | 2012 |
| Effect of luteinizing hormone–releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study B Gerber, G von Minckwitz, H Stehle, T Reimer, R Felberbaum, N Maass, ... Journal of clinical oncology 29 (17), 2334-2341, 2011 | 343 | 2011 |
